Trials / Completed
CompletedNCT01083147
Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Notal Vision Ltd. · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the compliance of the Foresee Home device in intermediate AMD patients.
Detailed description
This is a non-randomized cohort, multi-center study. The eligible subjects will be asked to use the FORESEE HOME device daily and the tests results will be automatically transmitted to the Data Monitor Center for analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FORESEE HOME | Home Monitoring |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-03-01
- Completion
- 2010-09-01
- First posted
- 2010-03-09
- Last updated
- 2010-09-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01083147. Inclusion in this directory is not an endorsement.